Omeprazol Bravet Teva Pharma (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Bravet Teva Pharma, is a proton pump inhibitor presented as a unknown strength/unknown form for gastroenteral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and is used in Helicobacter pylori eradication regimens in adult patients. GNH USA supplies Omeprazol Bravet Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Bravet Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is indicated for conditions that involve excess gastric acid secretion.

- Gastro‑oesophageal reflux disease: reduces heartburn and oesophageal irritation. - Peptic ulcer disease: promotes ulcer healing and reduces recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by maintaining a higher gastric pH.

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects: - Headache - Diarrhoea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angio‑edema) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) with long‑term use - Fracture risk increased with prolonged therapy - Interstitial nephritis - Liver enzyme elevations

When prescribing omeprazole, clinicians should consider several safety aspects.

- Assess renal and hepatic function: dose adjustment may be required in severe impairment. - Review concomitant medications: omeprazole can affect the absorption of drugs that need an acidic environment. - Monitor long‑term users for vitamin B12 deficiency and bone health. - Use with caution in patients with a history of Clostridioides difficile infection. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Omeprazole may interact with several medicines, requiring clinical awareness.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, consider alternative therapy. - Atazanavir and other protease inhibitors: markedly decreased absorption. - Methotrexate (high‑dose): increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation parameters. - Diazepam: increased plasma concentrations, observe for sedation. - Digoxin: modest rise in levels, check therapeutic range.